Accine News Today

The plant at the Biotech Park in Andharua will have the capacity to produce 2.4 crore doses of different vaccines per day. It is expected to produce over 15 vaccines for various diseases, including cholera and malaria

Emphasis on polio eradication, declared national emergency in the country, remains the government’s top priority

Rocketvax and Basel University therapy uses a modified coronavirus that activates an immune response - News - PharmaTimes

MyJournals.org - Science - Long-Term Safety Analysis of the ChAdOx1-nCoV-19 Corona Virus Vaccine: Results from a Prospective Observational Study in Priority Vaccinated Groups in North India (Drug Safety)

Modified influenza vaccine candidates have been developed in collaboration with GSK - News - PharmaTimes

MyJournals.org - Science - Rapidly progressive IgA nephropathy with membranoproliferative glomerulonephritis-like lesions in an elderly man following the third dose of an mRNA COVID-19 vaccine: a case report (BMC Nephrology)

According to Okinawa Institute of Science and Technology researchers, gut bacteria that break down a sugar called fucose may be suppressing our immune response to the Covid-19 mRNA vaccine (OIST).

Notable first clearance for R21/Matrix-M malaria vaccine for use in a specific country - News - PharmaTimes

Phase 3 trial of single-shot chikungunya vaccine candidate unfolds among an adolescent cohort - News - PharmaTimes

Positive results showed the TSST-1 vaccine is effective with immunisation lasting for at least two years - News - PharmaTimes